Old Web
English
Sign In
Acemap
>
authorDetail
>
Jayandharan G Rao
Jayandharan G Rao
Christian Medical College & Hospital
Acute promyelocytic leukemia
Arsenic trioxide
Medicine
Immunology
Bortezomib
3
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Proteasome Activity Is Dispensable for the Degradation of PML-RARα: Efficacy of Bortezomib Along with Arsenic Trioxide in the Treatment of Arsenic Sensitive and Resistant Acute Promyelocytic Leukemia
2014
Blood
Saravanan Ganesan
Ansu Abu Alex
Ezhilarasi Chendamarai
Nithya Balasundaram
Hamenth Kumar Palani
Sachin David
Jayandharan G Rao
Aby Abraham
Auro Viswabandya
Biju George
Alok Srivastava
Poonkuzhali Balasubramanian
Rose Ann Padua
Christine Chomienne
Vikram Mathews
Show All
Source
Cite
Save
Citations (1)
Rationale and Efficacy of Bortezomib in the Treatment of Acute Promyelocytic Leukemia in Combination with Arsenic Trioxide: In-Vitro and Phase I Data
2011
Blood
Saravanan Ganesan
Ezhilarasi Chendamarai
Jayandharan G Rao
Sangeetha Hareendran
Ansu Abu Alex
Rayaz Ahmed
Aby Abraham
Auro Viswabandhya
Biju George
Alok Srivastava
Vikram Mathews
Show All
Source
Cite
Save
Citations (0)
Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity
2006
Leukemia
Vikram Mathews
Salamun Desire
Biju George
Kavitha M. Lakshmi
Jayandharan G Rao
Auro Viswabandya
Ashish Bajel
Vivi M. Srivastava
Alok Srivastava
Mammen Chandy
Show All
Source
Cite
Save
Citations (33)
1